-
Adagene Raises $50 Million in Series C Funding
prnasia
March 28, 2018
Leading antibody discovery and development company Adagene Inc. today announced US$50 million Series C financing led by Sequoia China
-
Adagene Raises $50 Million in Series C Funding
biospace
March 28, 2018
Leading antibody discovery and development company Adagene Inc. today announced US$50 million Series C financing led by Sequoia China
-
DocDoc raises $5.45 M for product scaling
biospectrumasia
March 21, 2018
DocDoc controls the latest in clinical informatics, artificial intelligence and healthcare quality assessment across Asia's largest healthcare provider network to deliver powerful solutions
-
DocDoc raises US$5.45 million to boost patient empowerment in Asia's healthcare sector
prnasia
March 21, 2018
DocDoc, Asia's leading patient empowerment company, announced today that it has raised US$5.45 million in their latest round of funding
-
Crinetics Pharmaceuticals Snags $63.5 Million in Series B Funding
biospace
March 15, 2018
Five months after its lead drug began Phase I testing San Diego-based Crinetics Pharmaceuticals Inc has secured $63.5 million in Series B financing.
-
Maple raises $4 million in funding to advance virtual healthcare in Canada
biospace
March 12, 2018
Maple is Canada's only app providing patients with 24/7 on-demand access to doctors by secure text or video for advice, diagnosis, and prescriptions.
-
RegeneRx Secures $1 Million in Funding
biospace
March 05, 2018
RegeneRx Biopharmaceuticals, Inc. today announced that it entered into a Warrant Reprice Agreement whereby it received $1.03 million in warrant exercise proceeds.
-
BioCanCell Announces Terms of $25M Funding Round
biospace
January 24, 2018
BioCancell Therapeutics announced today that the company has implemented a non-binding glossary of terms for the private equity investment of the Company of approximately $ 25 million.
-
VitriCell Raises Over $1.2M in Series A Funding
biospace
January 24, 2018
VitriCell SA, a biotech company providing innovative and efficient solutions for cryopreservation of even the most sensitive cells, discloses today that it closed a series A round of fundraising in the second half of 2017 totaling over €1 million ($1.2M).
-
Google Backs Vaccitech's $27M Series A Funding Round
biospace
January 16, 2018
Vaccitech, an Oxford University spinout company developing a universal flu vaccine, among other vaccine-related products, has secured £20m ($27.1m) in Series A financing.